Wai Chun Bio-Technology (HKSE:00660) Shares Outstanding (Basic Average): 178.5 Mil (As of Dec. 2025)


HKSE:00660 Wai Chun Bio-Technology Ltd HKSE:00660
17 GF Score
Price HK$0.48
GF Value HK$0.13
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Wai Chun Bio-Technology Shares Outstanding (Basic Average)?

Wai Chun Bio-Technology HKSE:00660 -4.00% 17 Shares Outstanding (Basic Average) is 178.5 Mil as of Dec. 2025. GuruFocus rates HKSE:00660 with a GF Score™ of 17/100 and a GF Value™ of HK$0.13 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Wai Chun Bio-Technology's average basic shares outstanding for the quarter that ended in Dec. 2025 was 178.5 Mil.


Wai Chun Bio-Technology  (HKSE:00660) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Wai Chun Bio-Technology Shares Outstanding (Basic Average) Related Terms


Wai Chun Bio-Technology Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Wai Chun Bio-Technology's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wai Chun Bio-Technology Shares Outstanding (Basic Average) Chart

Wai Chun Bio-Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Jun22 Jun23 Jun24 Jun25
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.39 0.00 168.92 171.48 173.45

Wai Chun Bio-Technology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.48 171.48 171.48 175.43 178.48
HKSE:00660
17GF Score
Wai Chun Bio-Technology Ltd HKSE:00660
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wai Chun Bio-Technology Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 178.5 Mil mean?
Wai Chun Bio-Technology (HKSE:00660) has a Shares Outstanding (Basic Average) of 178.5 Mil as of Dec. 2025. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Wai Chun Bio-Technology and its competitors.
Is Wai Chun Bio-Technology's Shares Outstanding (Basic Average) too high?
Wai Chun Bio-Technology's current Shares Outstanding (Basic Average) is 178.5 Mil. Overall, Wai Chun Bio-Technology has a GF Score™ of 17/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wai Chun Bio-Technology's Shares Outstanding (Basic Average) compare to DOW?
Wai Chun Bio-Technology's Shares Outstanding (Basic Average) of 178.5 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Chemicals company?
A good Shares Outstanding (Basic Average) depends on the Chemicals industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Wai Chun Bio-Technology and its competitors. Wai Chun Bio-Technology's current Shares Outstanding (Basic Average) is 178.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wai Chun Bio-Technology stock overvalued right now?
Based on GuruFocus' analysis, Wai Chun Bio-Technology (HKSE:00660) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.13, compared to a current price of HK$0.48 — trading 269.2% above its estimated fair value. The current Shares Outstanding (Basic Average) is 178.5 Mil. Wai Chun Bio-Technology's overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Wai Chun Bio-Technology (HKSE:00660), the current Shares Outstanding (Basic Average) is 178.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wai Chun Bio-Technology (HKSE:00660) Overvalued in 2026?

Based on GuruFocus' analysis, Wai Chun Bio-Technology stock appears to be overvalued. The current stock price of HK$0.48 is trading 269.2% above its estimated GF Value™ of HK$0.13. GuruFocus considers Wai Chun Bio-Technology to be Significantly Overvalued.

Key valuation signals for HKSE:00660:

  • Shares Outstanding (Basic Average): 178.5 Mil
  • GF Value™: HK$0.13 vs. price of HK$0.48 (269.2% above fair value)
  • GF Score™: 17/100 with 7 warning signs

No single metric tells the full story. See the HKSE:00660 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Wai Chun Bio-Technology Business Description

Address 26 Harbour Road, Rooms 4001-02, 40th Floor, China Resources Building, Wanchai, Hong Kong, HKG
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.
17GF Score

Get the complete analysis for HKSE:00660

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.48
Price
HK$0.13
GF Value